-
Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failureRavnik-Oblak, Maja ; Mrevlje, Franc, 1946-Aim: Comparison of the effectiveness of combined therapy vs. an insulin regimen in NIDDM patients with secondary failure of oral hypoglycemic agents. Research design: 27 NIDDM patients were randomly ... allocated to Group A (n = 14,insulin) and Group B (n = 13, insulin and sulfonylurea) with crossover after 3 months. After the next 3 months a decision was made about the further treatment according to the metabolic control. The patients were then treated for another year with the more successful regimen. Metabolic control, residualbeta-cell secretory capacity, degree of peripheral insulin resistance (clamp) and insulin dose were followed during the whole study. Results: (median, interquartile range, in brackets; *, statistically significant difference at P < 0.05): the combined therapy was better than insulin alone in2/3 of patients. Glycemic control was better (HbA1c at 3 months: Group A = 7.9(1.1)% vs. Group B = 7.0(0.5)%*; HbA1c at 6 months: Group A = 7.4(1.5)% vs.Group B = 8.1(1.5)%. Insulin dose was lower during the combined therapy in the first 3 months: Group A = 0.62(0.18) U/kg body weight vs. Group B = 0.39(0.16) U/kg body weight*. Combined treatment was associated with increasedC-peptide excretion both fasting and postprandially. No significant differences in peripheral insulin resistance were noted between the two groups. The combined treatment remained successful even after one year. The two groups of patients with different effective treatment did not differ significantly in any of the observed parameters. Conclusions: the combined therapy was more effective than insulin alone. Its favourable effect persistedafter treatment for a year. It seems better to start the treatment ofthe oral failure with combined therapy compared with insulin first and laterfollowed by combined therapy. On the basis of the observed parameters it is impossible to determine in advance which kind of treatment is more suitablefVir: Diabetes research and clinical practice. - ISSN 0168-8227 (Letn. 30, št. 1, 1995, str. 27-35)Vrsta gradiva - članek, sestavni delLeto - 1995Jezik - angleškiCOBISS.SI-ID - 16761561
Avtor
Ravnik-Oblak, Maja |
Mrevlje, Franc, 1946-
Teme
Diabetes Mellitus, Non-Insulin-Dependent |
Blood |
Drug Therapy |
Sulfonylurea Compounds |
Therapeutic Use |
Blood Glucose |
Metabolism |
Hypoglycemic Agents |
Therapeutic Use |
Insulin |
Therapeutic Use |
Blood |
Secretion |
Middle Age |
Islets Of Langerhans |
Secretion |
Time Factors |
Treatment Outcome |
Body Mass Index |
C-Peptide |
Blood |
Cross-Over Studies |
Dose-Response Relationship, Drug |
Drug Therapy, Combination |
Follow-Up Studies |
Glucose Clamp Technique |
Hemoglobin A, Glycosylated |
Insulin Resistance |
Hipoglikemiki |
Inzulin |
Krvni sladkor |
Sladkorna bolezen, ne-inzulin-odvisna |
Sulfonilurea, spojine |
C-peptid |
Doza-odgovor, odnos, zdravilo |
Glukoza, zajetje, tehnika |
Hemoglobin A glikozilirani |
Insulinska rezistenca |
Langerhansovi otočki |
Navzkrižne študije |
Sledilne študije |
Srednja leta |
Telesna masa, indeks |
Zdravilo, terapija sestavljena |
Zdravljenje, izid |
Časovni faktorji
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Ravnik-Oblak, Maja | 01993 |
Mrevlje, Franc, 1946- | 08204 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.